No FEAR Act Annual Report - 2025
Accessible Version
Figure 1. Number of Board EEO complaints filed by fiscal year (FY 2021–25)
| Year | Annual number of formal complaints |
|---|---|
| 2021 | 6 |
| 2022 | 8 |
| 2023 | 6 |
| 2024 | 11 |
| 2025 | 4 |
| 5-year average number of complaints | 7 |
Figure 2. Total number of Board EEO complaints by basis (FY 2021–25)*
| Basis | Total number of Board EEO complaints (FY 2021–25) | |
|---|---|---|
| Race | 19 | |
| Color | 8 | |
| Religion | 13 | |
| Reprisal | 22 | |
| Sex | 21 | |
| National origin | 9 | |
| Equal Pay Act | 3 | |
| Age | 8 | |
| Disability | 8 | |
| Non EEO | 1 | |
| Genetic Information | 0 |
Note: Complaints can be filed alleging multiple issues, so the sum of the issues may exceed the total complaints filed.
Figure 3. Total number of Board EEO complaints by issue (FY 2021–25)
| Issue | Total number of Board EEO complaints (FY 2021–25) |
|---|---|
| Appointment/hire | 3 |
| Assignment of duties | 9 |
| Awards | 0 |
| Conversion to full-time | 0 |
| Disciplinary action (demotion, reprimand, removal, suspension, other) | 8 |
| Duty hours | 3 |
| Evaluation appraisal | 10 |
| Examination/test | 1 |
| Harassment (sexual & non-sexual) | 18 |
| Medical examination | 0 |
| Pay (including overtime) | 1 |
| Promotion/non-selection | 15 |
| Reassignment (denial & directed) | 1 |
| Reasonable accommodation | 8 |
| Reinstatement | 0 |
| Retirement | 3 |
| Termination | 7 |
| Terms/conditions of employment | 7 |
| Time and attendance | 3 |
| Training | 2 |
| Other | 7 |
| Totals | 106 |
Note: Complaints can be filed alleging multiple issues, so the sum of the issues may exceed the total complaints filed.
Figure 4. EEO investigation processing time of pending complaints in calendar days by fiscal year (FY 2021–25)
| Fiscal Year | Annual Average Investigation Processing Time | |
|---|---|---|
| 2021 | 239 | |
| 2022 | 178 | |
| 2023 | 172 | |
| 2024 | 163 | |
| 2025 | 174 |
Note: Horizontal dashed line marked at 180 calendar days represents the (Benchmark) statutory timeframe.